Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection
about
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strainsAntihelminthics in helminth-endemic areas: effects on HIV disease progressionDeworming helminth co-infected individuals for delaying HIV disease progressionTreatment of helminth co-infection in HIV-1 infected individuals in resource-limited settingsNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewImmunovirological parameters and cytokines in HIV infectionA systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patientsThe role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseasesThe enduring tale of T cells in HIV immunopathogenesisPredominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaquesAltered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malariaCytopathic Mechanisms of HIV-1Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewEpidemiology and interactions of Human Immunodeficiency Virus – 1 and Schistosoma mansoni in sub-Saharan AfricaMechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionOpportunistic infections in HIV disease.Understanding the HIV coreceptor switch from a dynamical perspective.The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa.Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamicsPlasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.Anaemia in acute HIV-1 subtype C infectionPleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomasCo-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.Triple NF-kB binding sites and LTR sequence similarities in HIV-1C isolates irrespective of helminth co-infectionAssociation between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Contrasting roles for TLR ligands in HIV-1 pathogenesis.Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsDistinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques.Visceral leishmaniasis and HIV coinfection in Latin AmericaAttenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation.Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammationChildren and Human Immunodeficiency Virus Infection: Opportunities and challenges.Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markersHigh Rate of Non-detectable HIV-1 RNA Among Antiretroviral Drug Naive HIV Positive Individuals in NigeriaComprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.Social and immunological differences among uninfected Brazilians exposed or unexposed to human immunodeficiency virus-infected partnersAnti-Inflammatory Therapy for Feline Immunodeficiency Virus Infection and Associated AIDS-Like Syndrome.
P2860
Q21142612-EB689DFA-62E8-4D90-BC58-9FB658A22293Q24185903-5AB2CBE7-F879-4BE9-82D2-BCDB72033A94Q24240113-20F51E16-A8FC-4BA4-AC34-249BA823FEC6Q24242130-60BF0817-0502-4702-8CE7-B0BCF9D83BA7Q26770401-0AFE19B2-69B0-4FC2-B278-F88E08D8A74DQ26829264-DF15CAB5-9B37-4631-891E-FD1E4EB2EFD2Q26849374-5309E199-B4AB-4E64-97CA-B92B7DD7752AQ26859106-385178D8-C2E0-4EC2-A516-B264C8A8766CQ27025707-343729EF-E510-457F-BECA-B8C7DE5D1657Q27319538-7FF0CCBB-96C9-4E36-B901-8267B270D84BQ27341794-8319517D-57CF-4351-B81D-9265D45C0270Q27485043-6040CED2-0514-4252-AB54-949EB83E9513Q27491003-CF3C2E05-F441-4B7F-ABDA-76505E419846Q27499293-5966D47F-75F4-4493-97CA-06CE35AB2815Q28081838-F7523BA7-55D8-4E3A-94C6-7B1CCA1D4FC2Q30391927-816DE4B0-0913-4680-8B9F-E586EA90A89EQ30931832-31F42B9E-7F84-46C5-8F81-838FB45C14E4Q31039330-F9F9DE04-D63A-4850-897C-14243DABFC95Q33274194-AED687CB-0319-46D6-90BC-5E26018286A1Q33284948-515024FC-1231-4222-BEE0-E5471DC45A72Q33320529-AB69AFC0-AD0A-4D5B-8B2F-44499CD866CFQ33401262-17A6BD12-7AED-4630-BBED-64928BB1F860Q33520335-5719D559-6D9F-45FB-9D12-2F7FB41C904CQ33533743-24E46B7D-7487-4CF3-8145-9F19F1F791C2Q33580261-E1B0FA1F-634C-4570-9539-218858EE7F8DQ33602772-7E2705D9-2011-4482-9E49-3091F678D941Q33700312-53233ECA-8D5E-4807-A5CE-5D5418AFCCA6Q33812820-68B480BA-EDAC-4CF6-A6E1-C02014A7B29EQ34016057-1F5F3B12-0EC3-47BB-9449-C631B6C57983Q34057868-087626E5-BE60-453C-A57C-553FEB9F143DQ34077805-F0B0CA62-7972-4B04-817F-33C816028C27Q34214794-94704B69-2474-410D-AB8B-3BEE825F29F2Q34300102-444D0864-8B95-461C-91B1-640BEBEDEB3FQ34335961-25B1A853-96E0-4077-A0C3-1C17D103AFB8Q34380524-DC5ABA5A-762C-480F-8836-93087D46FADCQ34431915-FB86B1C5-BA10-4F48-BDE5-16C3E6EB9F0FQ34463096-DAA8A353-9587-4BEC-8767-219C73A8F09CQ34487847-5411E5CC-5812-4C53-A04D-F0B4225DADA7Q34548445-1AEFAF92-6F15-4D93-BC32-5A458C4D0E8EQ34631387-A654C5D2-AEA1-470A-8CCE-71720CB426EE
P2860
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Contribution of immune activat ...... iciency virus type 1 infection
@ast
Contribution of immune activat ...... iciency virus type 1 infection
@en
Contribution of immune activat ...... iciency virus type 1 infection
@nl
type
label
Contribution of immune activat ...... iciency virus type 1 infection
@ast
Contribution of immune activat ...... iciency virus type 1 infection
@en
Contribution of immune activat ...... iciency virus type 1 infection
@nl
prefLabel
Contribution of immune activat ...... iciency virus type 1 infection
@ast
Contribution of immune activat ...... iciency virus type 1 infection
@en
Contribution of immune activat ...... iciency virus type 1 infection
@nl
P2093
P2860
P3181
P1476
Contribution of immune activat ...... iciency virus type 1 infection
@en
P2093
P2860
P304
753-77, table of contents
P3181
P356
10.1128/CMR.14.4.753-777.2001
P407
P577
2001-10-01T00:00:00Z